Ken Griffin Precision Biosciences Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.29 - $0.45 $96,237 - $149,334	331,854 Added 10.59%	3,465,763 $1.25 Million
Q3 2023 Nov 14, 2023	BUY	$0.34 - $0.69 $143,439 - $291,098	421,882 Added 15.56%	3,133,909 $1.07 Million
Q2 2023 Aug 14, 2023	SELL	$0.52 - $0.91 $65,201 - $114,102	-125,387 Reduced 4.42%	2,712,027 $1.44 Million
Q1 2023 May 15, 2023	BUY	$0.7 - $1.41 $606,472 - $1.22 Million	866,389 Added 43.96%	2,837,414 $2.13 Million
Q4 2022 Feb 14, 2023	BUY	$0.97 - $45.0 $209,997 - $9.74 Million	216,492 Added 12.34%	1,971,025 $2.35 Million
Q3 2022 Nov 14, 2022	BUY	$1.22 - $40.8 $406,318 - $13.6 Million	333,048 Added 23.43%	1,754,533 $2.28 Million
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $1.18 Million - $3.43 Million	1,025,936 Added 259.37%	1,421,485 $2.27 Million
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $1.02 Million - $2.67 Million	344,399 Added 673.31%	395,549 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$7.4 - $11.66 $1.1 Million - $1.73 Million	-148,282 Reduced 74.35%	51,150 $378,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $980,451 - $1.51 Million	106,803 Added 115.3%	199,432 $2.3 Million
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $1.1 Million - $1.71 Million	-136,701 Reduced 59.61%	92,629 $1.16 Million
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $10.9 Million - $20.2 Million	-1,277,445 Reduced 84.78%	229,330 $2.37 Million
Q4 2020 Feb 16, 2021	BUY	$5.98 - $12.47 $8.65 Million - $18 Million	1,445,982 Added 2378.53%	1,506,775 $12.6 Million
Q3 2020 Nov 16, 2020	BUY	$4.65 - $8.73 $50,866 - $95,497	10,939 Added 21.94%	60,793 $374,000
Q2 2020 Aug 14, 2020	SELL	$4.66 - $8.7 $497,389 - $928,603	-106,736 Reduced 68.16%	49,854 $415,000
Q1 2020 May 15, 2020	SELL	$5.05 - $15.01 $397,934 - $1.18 Million	-78,799 Reduced 33.48%	156,590 $945,000
Q4 2019 Feb 14, 2020	BUY	$6.32 - $19.66 $1.29 Million - $4 Million	203,545 Added 639.19%	235,389 $3.27 Million
Q3 2019 Nov 14, 2019	SELL	$8.03 - $14.82 $305,525 - $563,871	-38,048 Reduced 54.44%	31,844 $267,000
Q2 2019 Aug 14, 2019	BUY	$11.88 - $16.94 $256,512 - $365,768	21,592 Added 44.7%	69,892 $926,000
Q1 2019 May 15, 2019	BUY	$17.44 - $17.95 $842,352 - $866,985	48,300 New	48,300 $0

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.57 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.01 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$1.94 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.11 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$767,282
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $550M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account